Related Experiment Video
Updated: Sep 10, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The Role of Non-Coding RNAs in the Regulation of Oncogenic Pathways in Breast and Gynaecological Cancers
Ammar Ansari1, Aleksandra Szczesnowska1, Natalia Haddad1
1Department of Biomolecular Sciences, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston-upon-Thames KT1 2EE, UK.
Abstract:
Female cancers such as breast and gynaecological cancers contribute to a significant global health burden and are a leading cause of fatality among women. With current treatment options often limited by resistance to cytotoxic drugs, side effects and lack of specificity to the cancer, there is a pressing need for alternative treatments. Recent research has highlighted the promising role of non-coding RNAs (ncRNA) in regulating these issues and providing more targeted approaches to suppressing key cancer pathways. This review explores the involvement of the various types of non-coding RNAs in regulating key oncogenic pathways, namely, the MAPK, PI3K/Akt/mTOR, Wnt/β-catenin and p53 pathways, in a range of female cancers such as breast, cervical, ovarian and endometrial cancers. Evidence from a multitude of studies suggests that non-coding RNAs function as double-edged swords, serving as both oncogenes and tumour suppressors, depending on their expression and cellular interactions. By mapping and investigating these regulatory interactions, this review demonstrates the complexity and dual functionality of ncRNAs in cancer. Understanding these complex mechanisms is essential for the development of new and effective ncRNA-based diagnostic methods and targeted therapies in female cancer treatment.
Insights
Non-coding RNAs (ncRNAs) show promise as targeted therapies for female cancers. These molecules act as both oncogenes and tumor suppressors, offering new diagnostic and treatment strategies for breast, ovarian, and cervical cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Female cancers (breast, gynecological) pose a significant global health burden.
- Current treatments face limitations like drug resistance, side effects, and lack of specificity.
- There is a critical need for novel, targeted therapeutic strategies.
Purpose of the Study:
- To review the role of non-coding RNAs (ncRNAs) in regulating key oncogenic pathways in female cancers.
- To explore the dual functionality of ncRNAs as oncogenes and tumor suppressors.
- To highlight the potential of ncRNAs for developing new diagnostic and therapeutic approaches.
Main Methods:
- Literature review of studies investigating ncRNAs in female cancers.
- Analysis of ncRNA involvement in MAPK, PI3K/Akt/mTOR, Wnt/β-catenin, and p53 pathways.
- Examination of regulatory interactions and dual functionality of ncRNAs.
Main Results:
- Non-coding RNAs are implicated in the regulation of major oncogenic pathways in breast, cervical, ovarian, and endometrial cancers.
- ncRNAs exhibit complex, context-dependent roles, acting as both oncogenes and tumor suppressors.
- Evidence demonstrates the intricate regulatory networks involving ncRNAs in cancer progression.
Conclusions:
- Understanding the complex mechanisms of ncRNAs is crucial for advancing female cancer treatment.
- ncRNAs hold significant potential for the development of targeted therapies and diagnostic tools.
- Further research into ncRNA functionality can lead to more effective and specific cancer treatments.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Regulation of Expression at Multiple Steps
Types of RNA
RNA Performs Diverse...
Epigenetic Regulation
X-chromosome...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

